In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

Professor David Denning evaluates timely and accurate diagnosis of Aspergillus infection and the clinical spectrum of ...

Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW medical editor Dr. Brian McDonough has more.

A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...

Photo: Barry Cronin I drag myself out of bed, take my preventative inhaler and head to the gym. By taking the inhaler, I can ...

"This is important, because right now, inhaled pharmaceuticals are designed with a one-size-fits-all approach. But someone who has severe COPD, for example, is going to breathe very differently and ...

Compared with control patients, invited patients spent less out-of-pocket. Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for ...